Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132811) titled 'Evaluation, Prediction and Health Economic Analysis of Lecanemab Efficacy Based on Multimodal Digital Behavior and Blood Biomarkers: A Prospective Observational Cohort Study' on Sept. 18.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The first hospital of Shanxi Medical University
Condition:
Alzheimers disease
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Treatment Group and Control Group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=341077
Published by HT ...